Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Net Income (2016 - 2025)

Anaptysbio (ANAB) has disclosed Net Income for 10 consecutive years, with $49.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income rose 327.75% year-over-year to $49.6 million, compared with a TTM value of -$13.2 million through Dec 2025, up 90.89%, and an annual FY2025 reading of -$13.2 million, up 90.89% over the prior year.
  • Net Income was $49.6 million for Q4 2025 at Anaptysbio, up from $15.1 million in the prior quarter.
  • Across five years, Net Income topped out at $49.6 million in Q4 2025 and bottomed at -$46.7 million in Q2 2024.
  • Average Net Income over 5 years is -$23.9 million, with a median of -$31.2 million recorded in 2021.
  • The sharpest move saw Net Income crashed 6121.91% in 2022, then surged 327.75% in 2025.
  • Year by year, Net Income stood at -$31.1 million in 2021, then rose by 28.8% to -$22.1 million in 2022, then crashed by 90.51% to -$42.2 million in 2023, then soared by 48.34% to -$21.8 million in 2024, then soared by 327.75% to $49.6 million in 2025.
  • Business Quant data shows Net Income for ANAB at $49.6 million in Q4 2025, $15.1 million in Q3 2025, and -$38.6 million in Q2 2025.